5-methoxypsoralen has been researched along with Depression in 3 studies
5-Methoxypsoralen: A linear furanocoumarin that has phototoxic and anti-inflammatory properties, with effects similar to METHOXSALEN. It is used in PUVA THERAPY for the treatment of PSORIASIS.
5-methoxypsoralen : A 5-methoxyfurocoumarin that is psoralen substituted by a methoxy group at position 5.
Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Coumarins are a large family of compounds, of natural and synthetic origin, that exhibit a variety of pharmacological activities, including MAO inhibition." | 6.49 | A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease. ( Bari, SB; Deshmukh, PK; Donda, ST; Firke, SD; Patil, DA; Patil, PO, 2013) |
| "To investigate if the coumarins prolong the behavioral effects of nicotine, the forced swimming test (FST)-animal models of depression, and passive avoidance (PA) test-memory and learning paradigm were used." | 3.83 | In vivo modulation of the behavioral effects of nicotine by the coumarins xanthotoxin, bergapten, and umbelliferone. ( Biala, G; Budzynska, B; Kruk-Slomka, M; Skalicka-Wozniak, K; Wydrzynska-Kuzma, M, 2016) |
| "Coumarins are a large family of compounds, of natural and synthetic origin, that exhibit a variety of pharmacological activities, including MAO inhibition." | 2.49 | A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease. ( Bari, SB; Deshmukh, PK; Donda, ST; Firke, SD; Patil, DA; Patil, PO, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Patil, PO | 1 |
| Bari, SB | 1 |
| Firke, SD | 1 |
| Deshmukh, PK | 1 |
| Donda, ST | 1 |
| Patil, DA | 1 |
| Yan, M | 1 |
| Bo, X | 1 |
| Zhang, J | 1 |
| Liu, S | 1 |
| Li, X | 1 |
| Liao, Y | 1 |
| Liu, Q | 1 |
| Cheng, Y | 1 |
| Cheng, J | 1 |
| Budzynska, B | 1 |
| Skalicka-Wozniak, K | 1 |
| Kruk-Slomka, M | 1 |
| Wydrzynska-Kuzma, M | 1 |
| Biala, G | 1 |
1 review available for 5-methoxypsoralen and Depression
| Article | Year |
|---|---|
A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer's disease.
Topics: Alzheimer Disease; Coumarins; Depression; Drug Design; Humans; Models, Molecular; Molecular Structur | 2013 |
2 other studies available for 5-methoxypsoralen and Depression
| Article | Year |
|---|---|
Bergapten alleviates depression-like behavior by inhibiting cyclooxygenase 2 activity and NF-κB/MAPK signaling pathway in microglia.
Topics: 5-Methoxypsoralen; Animals; Cyclooxygenase 2; Depression; Depressive Disorder, Major; Humans; Lipopo | 2023 |
In vivo modulation of the behavioral effects of nicotine by the coumarins xanthotoxin, bergapten, and umbelliferone.
Topics: 5-Methoxypsoralen; Animals; Antidepressive Agents; Avoidance Learning; Behavior, Animal; Coumarins; | 2016 |